 | • レポートコード：MRC2-11QY04862 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はTNF阻害剤のグローバル市場について調査・分析したレポートです。種類別（単剤療法、併用療法）市場規模、用途別（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別TNF阻害剤の競争状況、市場シェア ・世界のTNF阻害剤市場：種類別市場規模 2015年-2020年（単剤療法、併用療法） ・世界のTNF阻害剤市場：種類別市場規模予測 2021年-2026年（単剤療法、併用療法） ・世界のTNF阻害剤市場：用途別市場規模 2015年-2020年（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他） ・世界のTNF阻害剤市場：用途別市場規模予測 2021年-2026年（皮膚病、強直性脊椎炎、胃腸疾患、関節リウマチ、その他） ・北米のTNF阻害剤市場分析：米国、カナダ ・ヨーロッパのTNF阻害剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのTNF阻害剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のTNF阻害剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのTNF阻害剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Novartis、Boehringer Ingelheim、Amgen、BioPharma、Mochida Pharmaceutical、Hanall ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and causes inflammation. TNF drugs are used to reduce inflammation and stop disease progression by targeting the tumor necrosis factor, which is an inflammation-causing substance. TNF inhibitor drugs are employed to treat inflammatory conditions such as rheumatoid arthritis and juvenile arthritis. Generally, in the healthy person, the TNF levels remain steady. However, in a patient with rheumatoid arthritis, the level of TNF is increasing which leads to more inflammation. TNF inhibitor drugs act as blockers for TNF substances. TNF alpha blockers are highly effective in the treatment of patients with active rheumatoid arthritis. These drugs are used in patients as a conventional second-line treatments.
The adalimumab segment is likely to expand at a significant pace during the forecast period. The drug is effectively used in a broad range of pain management therapies and is widely available over the counter. Based on distribution channel, the TNF inhibitors market can be segmented into hospital pharmacy and retail pharmacy. The hospital pharmacy segment is likely to expand at a significant pace between 2017 and 2025, this is because patients with rheumatoid arthritis, arthritis give more preference to the hospitals for treatment. Increase in elderly population and rise in the prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the factors that drive the TNF inhibitors market. According to the National Health Interview Survey, in 2016, almost 20% of the global population was reported to be suffering from chronic pain, with rheumatoid arthritis being one of the major reasons. Moreover, according to the Center for Disease Control and Prevention, by 2040, approximately 78 million (26%) of the U.S. adults are projected to have arthritis. Owing to this, the consumption of TNF inhibitor dugs is likely to increase rapidly in the near future. However, side-effects associated with the use of TNF inhibitor drugs such as skin irritation, flushing, headache, and abdominal pain are estimated to hinder the market in the next few years.
Market Analysis and Insights: Global TNF Inhibitors Market
The global TNF Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global TNF Inhibitors Scope and Market Size
TNF Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global TNF Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Novartis
Boehringer Ingelheim
Amgen
BioPharma
Mochida Pharmaceutical
Hanall
…
Market segment by Type, the product can be split into
Monotherapy
Combination Therapy
Market segment by Application, split into
Skin Disease
Ankylosing Spondylitis
Gastrointestinal Disease
Rheumatoid Arthritis
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by TNF Inhibitors Revenue
1.4 Market by Type
1.4.1 Global TNF Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global TNF Inhibitors Market Share by Application: 2020 VS 2026
1.5.2 Skin Disease
1.5.3 Ankylosing Spondylitis
1.5.4 Gastrointestinal Disease
1.5.5 Rheumatoid Arthritis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global TNF Inhibitors Market Perspective (2015-2026)
2.2 Global TNF Inhibitors Growth Trends by Regions
2.2.1 TNF Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 TNF Inhibitors Historic Market Share by Regions (2015-2020)
2.2.3 TNF Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 TNF Inhibitors Market Growth Strategy
2.3.6 Primary Interviews with Key TNF Inhibitors Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top TNF Inhibitors Players by Market Size
3.1.1 Global Top TNF Inhibitors Players by Revenue (2015-2020)
3.1.2 Global TNF Inhibitors Revenue Market Share by Players (2015-2020)
3.1.3 Global TNF Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global TNF Inhibitors Market Concentration Ratio
3.2.1 Global TNF Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by TNF Inhibitors Revenue in 2019
3.3 TNF Inhibitors Key Players Head office and Area Served
3.4 Key Players TNF Inhibitors Product Solution and Service
3.5 Date of Enter into TNF Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global TNF Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global TNF Inhibitors Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global TNF Inhibitors Market Size by Application (2015-2020)
5.2 Global TNF Inhibitors Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America TNF Inhibitors Market Size (2015-2020)
6.2 TNF Inhibitors Key Players in North America (2019-2020)
6.3 North America TNF Inhibitors Market Size by Type (2015-2020)
6.4 North America TNF Inhibitors Market Size by Application (2015-2020)
7 Europe
7.1 Europe TNF Inhibitors Market Size (2015-2020)
7.2 TNF Inhibitors Key Players in Europe (2019-2020)
7.3 Europe TNF Inhibitors Market Size by Type (2015-2020)
7.4 Europe TNF Inhibitors Market Size by Application (2015-2020)
8 China
8.1 China TNF Inhibitors Market Size (2015-2020)
8.2 TNF Inhibitors Key Players in China (2019-2020)
8.3 China TNF Inhibitors Market Size by Type (2015-2020)
8.4 China TNF Inhibitors Market Size by Application (2015-2020)
9 Japan
9.1 Japan TNF Inhibitors Market Size (2015-2020)
9.2 TNF Inhibitors Key Players in Japan (2019-2020)
9.3 Japan TNF Inhibitors Market Size by Type (2015-2020)
9.4 Japan TNF Inhibitors Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia TNF Inhibitors Market Size (2015-2020)
10.2 TNF Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia TNF Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia TNF Inhibitors Market Size by Application (2015-2020)
11 India
11.1 India TNF Inhibitors Market Size (2015-2020)
11.2 TNF Inhibitors Key Players in India (2019-2020)
11.3 India TNF Inhibitors Market Size by Type (2015-2020)
11.4 India TNF Inhibitors Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America TNF Inhibitors Market Size (2015-2020)
12.2 TNF Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America TNF Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America TNF Inhibitors Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer TNF Inhibitors Introduction
13.1.4 Pfizer Revenue in TNF Inhibitors Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis TNF Inhibitors Introduction
13.2.4 Novartis Revenue in TNF Inhibitors Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Details
13.3.2 Boehringer Ingelheim Business Overview
13.3.3 Boehringer Ingelheim TNF Inhibitors Introduction
13.3.4 Boehringer Ingelheim Revenue in TNF Inhibitors Business (2015-2020)
13.3.5 Boehringer Ingelheim Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen TNF Inhibitors Introduction
13.4.4 Amgen Revenue in TNF Inhibitors Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 BioPharma
13.5.1 BioPharma Company Details
13.5.2 BioPharma Business Overview
13.5.3 BioPharma TNF Inhibitors Introduction
13.5.4 BioPharma Revenue in TNF Inhibitors Business (2015-2020)
13.5.5 BioPharma Recent Development
13.6 Mochida Pharmaceutical
13.6.1 Mochida Pharmaceutical Company Details
13.6.2 Mochida Pharmaceutical Business Overview
13.6.3 Mochida Pharmaceutical TNF Inhibitors Introduction
13.6.4 Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2015-2020)
13.6.5 Mochida Pharmaceutical Recent Development
13.7 Hanall
13.7.1 Hanall Company Details
13.7.2 Hanall Business Overview
13.7.3 Hanall TNF Inhibitors Introduction
13.7.4 Hanall Revenue in TNF Inhibitors Business (2015-2020)
13.7.5 Hanall Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. TNF Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by TNF Inhibitors Revenue
Table 3. Ranking of Global Top TNF Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global TNF Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. Global TNF Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global TNF Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global TNF Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global TNF Inhibitors Market Share by Regions (2015-2020)
Table 11. Global TNF Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global TNF Inhibitors Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. TNF Inhibitors Market Growth Strategy
Table 17. Main Points Interviewed from Key TNF Inhibitors Players
Table 18. Global TNF Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 19. Global TNF Inhibitors Market Share by Players (2015-2020)
Table 20. Global Top TNF Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TNF Inhibitors as of 2019)
Table 21. Global TNF Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players TNF Inhibitors Product Solution and Service
Table 24. Date of Enter into TNF Inhibitors Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 27. Global TNF Inhibitors Market Size Share by Type (2015-2020)
Table 28. Global TNF Inhibitors Revenue Market Share by Type (2021-2026)
Table 29. Global TNF Inhibitors Market Size Share by Application (2015-2020)
Table 30. Global TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 31. Global TNF Inhibitors Market Size Share by Application (2021-2026)
Table 32. North America Key Players TNF Inhibitors Revenue (2019-2020) (Million US$)
Table 33. North America Key Players TNF Inhibitors Market Share (2019-2020)
Table 34. North America TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 35. North America TNF Inhibitors Market Share by Type (2015-2020)
Table 36. North America TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 37. North America TNF Inhibitors Market Share by Application (2015-2020)
Table 38. Europe Key Players TNF Inhibitors Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players TNF Inhibitors Market Share (2019-2020)
Table 40. Europe TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 41. Europe TNF Inhibitors Market Share by Type (2015-2020)
Table 42. Europe TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 43. Europe TNF Inhibitors Market Share by Application (2015-2020)
Table 44. China Key Players TNF Inhibitors Revenue (2019-2020) (Million US$)
Table 45. China Key Players TNF Inhibitors Market Share (2019-2020)
Table 46. China TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 47. China TNF Inhibitors Market Share by Type (2015-2020)
Table 48. China TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 49. China TNF Inhibitors Market Share by Application (2015-2020)
Table 50. Japan Key Players TNF Inhibitors Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players TNF Inhibitors Market Share (2019-2020)
Table 52. Japan TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 53. Japan TNF Inhibitors Market Share by Type (2015-2020)
Table 54. Japan TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 55. Japan TNF Inhibitors Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players TNF Inhibitors Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players TNF Inhibitors Market Share (2019-2020)
Table 58. Southeast Asia TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia TNF Inhibitors Market Share by Type (2015-2020)
Table 60. Southeast Asia TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia TNF Inhibitors Market Share by Application (2015-2020)
Table 62. India Key Players TNF Inhibitors Revenue (2019-2020) (Million US$)
Table 63. India Key Players TNF Inhibitors Market Share (2019-2020)
Table 64. India TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 65. India TNF Inhibitors Market Share by Type (2015-2020)
Table 66. India TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 67. India TNF Inhibitors Market Share by Application (2015-2020)
Table 68. Central & South America Key Players TNF Inhibitors Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players TNF Inhibitors Market Share (2019-2020)
Table 70. Central & South America TNF Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America TNF Inhibitors Market Share by Type (2015-2020)
Table 72. Central & South America TNF Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America TNF Inhibitors Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in TNF Inhibitors Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in TNF Inhibitors Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Boehringer Ingelheim Company Details
Table 85. Boehringer Ingelheim Business Overview
Table 86. Boehringer Ingelheim Product
Table 87. Boehringer Ingelheim Revenue in TNF Inhibitors Business (2015-2020) (Million US$)
Table 88. Boehringer Ingelheim Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Product
Table 92. Amgen Revenue in TNF Inhibitors Business (2015-2020) (Million US$)
Table 93. Amgen Recent Development
Table 94. BioPharma Company Details
Table 95. BioPharma Business Overview
Table 96. BioPharma Product
Table 97. BioPharma Revenue in TNF Inhibitors Business (2015-2020) (Million US$)
Table 98. BioPharma Recent Development
Table 99. Mochida Pharmaceutical Company Details
Table 100. Mochida Pharmaceutical Business Overview
Table 101. Mochida Pharmaceutical Product
Table 102. Mochida Pharmaceutical Revenue in TNF Inhibitors Business (2015-2020) (Million US$)
Table 103. Mochida Pharmaceutical Recent Development
Table 104. Hanall Company Details
Table 105. Hanall Business Overview
Table 106. Hanall Product
Table 107. Hanall Revenue in TNF Inhibitors Business (2015-2020) (Million US$)
Table 108. Hanall Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global TNF Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global TNF Inhibitors Market Share by Application: 2020 VS 2026
Figure 5. Skin Disease Case Studies
Figure 6. Ankylosing Spondylitis Case Studies
Figure 7. Gastrointestinal Disease Case Studies
Figure 8. Rheumatoid Arthritis Case Studies
Figure 9. Others Case Studies
Figure 10. TNF Inhibitors Report Years Considered
Figure 11. Global TNF Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global TNF Inhibitors Market Share by Regions: 2020 VS 2026
Figure 13. Global TNF Inhibitors Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global TNF Inhibitors Market Share by Players in 2019
Figure 16. Global Top TNF Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TNF Inhibitors as of 2019
Figure 17. The Top 10 and 5 Players Market Share by TNF Inhibitors Revenue in 2019
Figure 18. North America TNF Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe TNF Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China TNF Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan TNF Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia TNF Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India TNF Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America TNF Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
強直性脊椎炎治療の世界市場（～2026年） Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and p…- 強直性脊椎炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ankylosing Spondylitis Drug Market The global Ankylosing Spondylitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ankylosing Spondylitis Drug Scope and Market Size Ankylosin…
- 関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- シグナル伝達阻害剤の世界市場（～2026年） Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues. Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibit…
- DPP IV阻害剤（DPP-4阻害剤）の世界市場（～2026年） DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of in…